CYP2J2

Revision as of 15:15, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
Jump to navigation Jump to search


Cytochrome P450, family 2, subfamily J, polypeptide 2
Identifiers
Symbols CYP2J2 ; CPJ2
External IDs Template:OMIM5 Template:MGI HomoloGene68091
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

WikiDoc Resources for CYP2J2

Articles

Most recent articles on CYP2J2

Most cited articles on CYP2J2

Review articles on CYP2J2

Articles on CYP2J2 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CYP2J2

Images of CYP2J2

Photos of CYP2J2

Podcasts & MP3s on CYP2J2

Videos on CYP2J2

Evidence Based Medicine

Cochrane Collaboration on CYP2J2

Bandolier on CYP2J2

TRIP on CYP2J2

Clinical Trials

Ongoing Trials on CYP2J2 at Clinical Trials.gov

Trial results on CYP2J2

Clinical Trials on CYP2J2 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CYP2J2

NICE Guidance on CYP2J2

NHS PRODIGY Guidance

FDA on CYP2J2

CDC on CYP2J2

Books

Books on CYP2J2

News

CYP2J2 in the news

Be alerted to news on CYP2J2

News trends on CYP2J2

Commentary

Blogs on CYP2J2

Definitions

Definitions of CYP2J2

Patient Resources / Community

Patient resources on CYP2J2

Discussion groups on CYP2J2

Patient Handouts on CYP2J2

Directions to Hospitals Treating CYP2J2

Risk calculators and risk factors for CYP2J2

Healthcare Provider Resources

Symptoms of CYP2J2

Causes & Risk Factors for CYP2J2

Diagnostic studies for CYP2J2

Treatment of CYP2J2

Continuing Medical Education (CME)

CME Programs on CYP2J2

International

CYP2J2 en Espanol

CYP2J2 en Francais

Business

CYP2J2 in the Marketplace

Patents on CYP2J2

Experimental / Informatics

List of terms related to CYP2J2


Cytochrome P450, family 2, subfamily J, polypeptide 2, also known as CYP2J2, is a human gene.[1]

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue.[1]

References

  1. 1.0 1.1 "Entrez Gene: CYP2J2 cytochrome P450, family 2, subfamily J, polypeptide 2".

Further reading

  • Scarborough PE, Ma J, Qu W, Zeldin DC (1999). "P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues". Drug Metab. Rev. 31 (1): 205–34. PMID 10065373.
  • Capdevila JH, Falck JR, Harris RC (2000). "Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase". J. Lipid Res. 41 (2): 163–81. PMID 10681399.
  • Wu S, Moomaw CR, Tomer KB; et al. (1996). "Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart". J. Biol. Chem. 271 (7): 3460–8. PMID 8631948.
  • Zeldin DC, Foley J, Ma J; et al. (1996). "CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance". Mol. Pharmacol. 50 (5): 1111–7. PMID 8913342.
  • Zeldin DC, Foley J, Boyle JE; et al. (1997). "Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas". Endocrinology. 138 (3): 1338–46. PMID 9048644.
  • Zeldin DC, Foley J, Goldsworthy SM; et al. (1997). "CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance". Mol. Pharmacol. 51 (6): 931–43. PMID 9187259.
  • Ma J, Ramachandran S, Fiedorek FT, Zeldin DC (1998). "Mapping of the CYP2J cytochrome P450 genes to human chromosome 1 and mouse chromosome 4". Genomics. 49 (1): 152–5. doi:10.1006/geno.1998.5235. PMID 9570962.
  • Bylund J, Finnström N, Oliw EH (1999). "Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles". Biochem. Biophys. Res. Commun. 261 (1): 169–74. doi:10.1006/bbrc.1999.1011. PMID 10405341.
  • Gu J, Su T, Chen Y; et al. (2000). "Expression of biotransformation enzymes in human fetal olfactory mucosa: potential roles in developmental toxicity". Toxicol. Appl. Pharmacol. 165 (2): 158–62. doi:10.1006/taap.2000.8923. PMID 10828211.
  • King LM, Ma J, Srettabunjong S; et al. (2002). "Cloning of CYP2J2 gene and identification of functional polymorphisms". Mol. Pharmacol. 61 (4): 840–52. PMID 11901223.
  • Matsumoto S, Hirama T, Matsubara T; et al. (2003). "Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole". Drug Metab. Dispos. 30 (11): 1240–5. PMID 12386130.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Marden NY, Fiala-Beer E, Xiang SH, Murray M (2003). "Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia". Biochem. J. 373 (Pt 3): 669–80. doi:10.1042/BJ20021903. PMID 12737630.
  • Pucci L, Lucchesi D, Chirulli V; et al. (2004). "Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus". American journal of pharmacogenomics : genomics-related research in drug development and clinical practice. 3 (5): 355–8. PMID 14575523.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Seubert J, Yang B, Bradbury JA; et al. (2005). "Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway". Circ. Res. 95 (5): 506–14. doi:10.1161/01.RES.0000139436.89654.c8. PMID 15256482.
  • Xiao YF, Ke Q, Seubert JM; et al. (2005). "Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2". Mol. Pharmacol. 66 (6): 1607–16. doi:10.1124/mol.104.004150. PMID 15361551.
  • Spiecker M, Darius H, Hankeln T; et al. (2005). "Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2". Circulation. 110 (15): 2132–6. doi:10.1161/01.CIR.0000143832.91812.60. PMID 15466638.


Template:WH Template:WikiDoc Sources